Premium
EGFR expression in primary squamous cell carcinoma of the thyroid
Author(s) -
Long Jennifer L.,
Strocker Ali M.,
Wang Marilene B.,
Blackwell Keith E.
Publication year - 2009
Publication title -
the laryngoscope
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.181
H-Index - 148
eISSN - 1531-4995
pISSN - 0023-852X
DOI - 10.1002/lary.20062
Subject(s) - epidermal growth factor receptor , thyroid , basal cell , cancer research , medicine , thyroid carcinoma , oncology , carcinoma , primary (astronomy) , pathology , receptor , physics , astronomy
We present the case of a 57‐year‐old male with primary squamous cell carcinoma of the thyroid (PSCCT). Epidermal growth factor receptor (EGFR) staining was strongly positive. Pharmaceuticals targeting EGFR may provide an additional therapeutic option for this rare disease with extremely poor prognosis. Laryngoscope, 119:89–90, 2009